| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11010904 | Molecular Genetics and Metabolism | 2018 | 8 Pages |
Abstract
This is the first indication that a 2â¯mg dose of nitisinone slows down the clinical progression of AKU. Combined ocular and ear ochronosis progression was arrested by nitisinone.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ranganath L.R., Khedr M., Milan A.M., Davison A.S., Hughes A.T., Usher J.L., Taylor S., Loftus N., Daroszewska A., West E., Jones A., Briggs M., Fisher M., McCormick M., Judd S., Vinjamuri S., Griffin R., Psarelli E.E., Gallagher J.A.,